Similar reasoning leads to the conclusion that many so-called specific disease therapies actually focus on these common intermediate pathobiological mechanisms rather than on the specific underlying disease determinants, such as the use of antithrombotics in acute myocardial infarction, or the use of anti–tumor necrosis factor therapies for rheumatoid arthritis.
